Want to see IN:PGHH full AI Analyst Report?
Top Page
Procter & Gamble Hygiene & Health Care Ltd.
(PGHH)
Select Model
Select Model
Rating:69Neutral
Price Target:
₹7,446.00
▼(-16.93% Downside)
Action:Reiterated
Date:10/01/26
The score is driven primarily by strong financial performance (high margins, excellent balance-sheet strength, and solid cash conversion). This is offset by very weak technical momentum (below all major moving averages with negative MACD), while valuation is mixed—supported by a strong dividend yield but constrained by a relatively high P/E.
Positive Factors
Branded FMCG platform
PGHH combines recognized feminine-hygiene and health-care brands with broad Indian distribution, supporting repeat purchases and product availability. This branded FMCG model can sustain customer familiarity and recurring demand while providing a durable base for merchandising and portfolio development.
Negative Factors
Recent revenue contraction
The latest annual revenue decline interrupts the prior expansion trend and raises questions about demand, pricing, product mix, or other business factors. Even with margins holding up, prolonged top-line weakness could limit operating leverage, brand investment capacity, and future earnings growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Branded FMCG platform
PGHH combines recognized feminine-hygiene and health-care brands with broad Indian distribution, supporting repeat purchases and product availability. This branded FMCG model can sustain customer familiarity and recurring demand while providing a durable base for merchandising and portfolio development.
Read all positive factors
Procter & Gamble Hygiene & Health Care Ltd. (PGHH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹222.53B
Dividend Yield4.28%
Average Volume (3M)1.43K
Price to Earnings (P/E)28.1
Beta (1Y)0.42
Revenue Growth-1.54%
EPS Growth-4.58%
CountryIN
Employees439
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)254.65
Shares Outstanding32,460,735
10 Day Avg. Volume1,077
30 Day Avg. Volume1,430
Financial Highlights & Ratios
PEG Ratio40.59
Price to Book (P/B)42.00
Price to Sales (P/S)7.39
P/FCF Ratio36.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)255.63
Revenue Forecast (FY)₹46.50B
Procter & Gamble Hygiene & Health Care Ltd. Business Overview & Revenue Model
Company Description
Established in 1964 and headquartered in Mumbai, India, Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of Procter & Gamble Overseas India BV. The company specializes in the manufacturing and worldwide distribution of bra...
How the Company Makes Money
PGHH primarily makes money by selling branded consumer products in India, generating revenue from the sale of its hygiene and health care portfolio to distributors, wholesalers, retailers, pharmacies, and other trade customers who then sell to end...
Procter & Gamble Hygiene & Health Care Ltd. Financial Statement Overview
Summary
Income Statement
83
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
88
Very Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.19B | 42.82B | 44.99B | 41.92B | 39.05B | 37.92B |
| Gross Profit | 26.99B | 24.73B | 25.48B | 23.52B | 20.24B | 20.30B |
| EBITDA | 11.78B | 11.97B | 12.11B | 10.23B | 9.09B | 8.54B |
| Net Income | 8.27B | 8.56B | 8.49B | 6.75B | 6.78B | 5.76B |
Balance Sheet | ||||||
| Total Assets | 17.55B | 18.04B | 17.55B | 18.59B | 21.37B | 16.81B |
| Cash, Cash Equivalents and Short-Term Investments | 5.16B | 5.68B | 4.81B | 5.74B | 9.64B | 6.25B |
| Total Debt | 23.20M | 8.70M | 23.20M | 30.80M | 40.30M | 51.00M |
| Total Liabilities | 10.18B | 10.50B | 10.18B | 10.84B | 11.91B | 9.44B |
| Stockholders Equity | 7.37B | 7.53B | 7.37B | 7.75B | 9.46B | 7.38B |
Cash Flow | ||||||
| Free Cash Flow | 6.08B | 8.75B | 5.63B | 4.26B | 7.81B | 5.23B |
| Operating Cash Flow | 6.76B | 9.24B | 6.18B | 4.71B | 8.26B | 5.73B |
| Investing Cash Flow | -586.30M | 113.70M | -586.30M | 10.60M | -99.10M | -268.50M |
| Financing Cash Flow | -6.66B | -8.45B | -6.66B | -8.62B | -4.77B | -5.69B |
Procter & Gamble Hygiene & Health Care Ltd. Technical Analysis
Negative
8963.95
Price Trends
7336.92
Negative
8044.18
Negative
9294.68
Negative
Market Momentum
-128.69
Negative
39.63
Neutral
36.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PGHH, the sentiment is Negative. The current price of 8963.95 is above the 20-day moving average (MA) of 6912.91, above the 50-day MA of 7336.92, and below the 200-day MA of 9294.68, indicating a bearish trend. The MACD of -128.69 indicates Negative momentum. The RSI at 39.63 is Neutral, neither overbought nor oversold. The STOCH value of 36.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:PGHH.
Procter & Gamble Hygiene & Health Care Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹1.04T | 54.87 | ― | 0.50% | 25.00% | 12.83% | |
69 Neutral | ₹222.53B | 28.13 | ― | 4.28% | -1.54% | -4.58% | |
69 Neutral | ₹4.38T | 29.09 | ― | 2.20% | 6.41% | 38.32% | |
67 Neutral | ₹433.74B | 31.89 | ― | 3.01% | 8.72% | 2.71% | |
65 Neutral | ₹649.27B | 32.88 | ― | 2.25% | 7.40% | 10.63% | |
59 Neutral | ₹834.22B | 42.32 | ― | 2.44% | 12.02% | 8.49% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:PGHH
Procter & Gamble Hygiene & Health Care Ltd.
6,855.45
-6,237.03
-47.64%
IN:COLPAL
Colgate-Palmolive (India) Limited
1,594.70
-580.27
-26.68%
IN:DABUR
Dabur India Limited
366.00
-128.29
-25.95%
IN:GODREJCP
Godrej Consumer Products Limited
815.10
-341.22
-29.51%
IN:HINDUNILVR
Hindustan Unilever Limited
1,864.00
-515.09
-21.65%
IN:MARICO
Marico Limited
800.75
82.68
11.51%
Procter & Gamble Hygiene & Health Care Ltd. Corporate Events
P&G Hygiene Resets Dividend Record Date Ahead of September AGM
Aug 7, 2026
Procter Gamble Hygiene and Health Care Limited has revised the record date for determining shareholders eligible for dividend and participation at its 62nd Annual General Meeting to 1 September 2026. The AGM will be held on 8 September 2026, and,...
P&G Hygiene Sets AGM and Dividend Timeline for September 2026
Aug 7, 2026
Procter Gamble Hygiene and Health Care Ltd. has scheduled its 62nd Annual General Meeting for September 8, 2026, as disclosed to both BSE and the National Stock Exchange. The company has set September 1, 2026 as the record date for determining sh...
P&G Hygiene and Health Care names new Sales Head as leadership shifts to Korea role
Jul 1, 2026
Procter Gamble Hygiene and Health Care Ltd. announced a leadership transition in its sales function, with seasoned executive Gopalakrishnan Kalianna set to become Sales Head effective August 1, 2026. Kalianna brings over two decades of experience...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.